Clinical Trial Update: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating levofloxacin to prevent infections in young patients with acute leukemia undergoing chemotherapy or stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection in Immunocompromised Pediatric Patients
• Leukemia in Children

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Leukemias of Ambiguous Lineage, Bacterial Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-06-26